Form 4: BioMarin Executive Charles Guyer Acquires Shares Through RSU Vesting

Charles Greg Guyer, EVP and Chief Technical Officer of BioMarin Pharmaceutical Inc., acquired shares of common stock through the vesting of Restricted Stock Units (RSUs) based on performance metrics.

Summary

• Charles Greg Guyer, an executive at BioMarin Pharmaceutical Inc., acquired shares of the company's common stock on February 27, 2024.
• The acquisition was through the vesting of Restricted Stock Units (RSUs).
• These RSUs were earned based on performance metrics related to total shareholder return, strategic goals, and non-GAAP income over the periods spanning 2021 through 2023.
• Mr. Guyer acquired 20,840 RSUs based on relative total shareholder return, 9,063 RSUs based on strategic goals achieved, and 6,284 RSUs based on non-GAAP income.
• The RSUs vest on March 15, 2024, subject to Mr. Guyer's continued service through that date.
• Following these transactions, Mr. Guyer beneficially owns 88,201 shares of BioMarin common stock.

Sentiment

Score: 6

Explanation: The document is a routine SEC filing related to executive compensation. It doesn't contain any particularly positive or negative news, but the vesting of RSUs suggests that performance goals were met.

Positives

• The vesting of RSUs indicates that performance goals were met, which could be seen as a positive sign for the company's performance during the 2021-2023 period.
• Executive ownership aligning with company performance can be viewed favorably by investors.

Industry Context

Executive compensation through equity grants is a common practice in the pharmaceutical industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded pharmaceutical companies.
• Companies like Amgen, Gilead, and Vertex also utilize RSUs and stock options as part of their executive compensation packages.
• The specific metrics used for vesting (total shareholder return, strategic goals, non-GAAP income) are common performance indicators used in the industry to incentivize executives.

Stakeholder Impact

• Shareholders may view the RSU vesting as a positive sign, indicating that the company met certain performance goals.
• Employees may be motivated by the fact that executive compensation is tied to company performance.

Key Dates